Spots Global Cancer Trial Database for A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer
Official Title: An Open-label, Randomized, Multi-center, Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer Dosed for Thirteen 28-day Cycles
Study ID: NCT00116779
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study was to contribute, along with other such dose-finding studies, to the identification of the most effective treatment regimen for a one month depot injection of degarelix in the treatment of prostate cancer by a rapid and sustained suppression of testosterone.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Urology Centers of Alabama, Homewood, Alabama, United States
Alaska Clinical Research Center, LLC, Anchorage, Alaska, United States
Advanced Urology Medical Center, Anaheim, California, United States
South Orange County Medical Research Cnter, Laguna Woods,, California, United States
Pacific Clinical Research, Santa Monica, California, United States
West Coast Clinical Research, Tarzana, California, United States
Western Clinical Research, Torrance, California, United States
Urology Associate PC, Denver, Colorado, United States
South Florida Medical Research, Aventura, Florida, United States
SW Florida Urological Associates, Fort Myers, Florida, United States
Florida Foundation for Healthcare Research, Ocala, Florida, United States
RMD Clinical Reseach Institution LLC, Melrose Park, Illinois, United States
Northeast Indiana Research, LLC, Fort Wayne, Indiana, United States
Regional Urology, Shreveport, Louisiana, United States
Nevada Urology Associates, Reno, Nevada, United States
Lawrenceville Urology, Lawrenceville, New Jersey, United States
Hudson Valley Urology PC, Poughkeepsie, New York, United States
The Urology Center, Greensboro, North Carolina, United States
State College Urologic Association, State College, Pennsylvania, United States
Univeristy Urological Research Institute, Providence, Rhode Island, United States
Urology San Antonio Research, San Antonio, Texas, United States
Scott & White Memorial Hospital, Temple, Texas, United States
University of Vermont, Dept of Surgery, South Burlington, Vermont, United States
Virginia Urology Center, Richmond, Virginia, United States
Office of Jeffrey Frankel, Seattle, Washington, United States
Wyoming Research Foundation, Cheyenne, Wyoming, United States
Southern Interior Medical Research Corporation, Kelowna, British Columbia, Canada
Dr. Cal Abdreau Research, Surrey, British Columbia, Canada
Can-Med Clinical Research, Inc., Victoria, British Columbia, Canada
Dr. Gary Steinhoff Clinical Research, Victoria, British Columbia, Canada
Valley Professional Center, Kentville, Nova Scotia, Canada
The Male and Female Health and Research Centers, Barrie, Ontario, Canada
Brantford Urology Research, Brantford, Ontario, Canada
Burlington Professional Care, Burlington, Ontario, Canada
The Female/Male Health Centres, Oakville, Ontario, Canada
Contact Details
Name: Clinical Development Support
Affiliation: Ferring Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
